Webinar On-Demand: Shift the Paradigm to Centrifuge-less Immuno-staining of Cells for Superior Viability, Recovery & Data

Manufacturing Living Therapies

Enabling “next-generation” drugs through automation and standardization This article was first published on Charles River Laboratories Eureka Blog. Please support our partners at Charles River. Cell and gene therapy continues to drive biopharmaceutical investment and pipelines, despite COVID-related research and clinical trial disruptions. Last year, the global cell therapy market size was $7.8 billion, expanding annually […]